Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
KBIO vs. ETF Alternatives
KaloBios Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development of monoclonal antibody therapeutics for diseases that burdens the society and to patients and their families.
Other News & PR